CIBC World Market
RXST icon

CIBC World Market’s RxSight RXST Stock Holding History

CIBC World Market’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,405
Closed -$218K – 1431
2024
Q3 		$218K Hold
4,405
– – ﹤0.01% 1214
2024
Q2 		$265K Buy
4,405
+245
+6% +$14K ﹤0.01% 1129
2024
Q1 		$215K Buy
+4,160
New +$204K ﹤0.01% 1215

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

CIBC World Market's RXST Position: Q4 2024 in Review

CIBC World Market sold out of RxSight (RXST) in Q4 2024, closing a stake of 4,405 shares — an estimated $218K sold.

CIBC World Market first reported a position in RXST in Q1 2024 and held it in 3 quarters. The position peaked at $265K in Q2 2024. 212 funds tracked by Wall St. Rank hold RXST as of Q4 2024.

  • CIBC World Market reported no remaining RxSight position as of Q4 2024 after selling out during the quarter.
  • CIBC World Market sold 4,405 RxSight shares in Q4 2024, an estimated $218K.
  • CIBC World Market first reported a position in RxSight in Q1 2024 and held it in 3 quarters.
  • CIBC World Market's RxSight position peaked at $265K in Q2 2024.
  • 212 funds tracked by Wall St. Rank held RxSight as of Q4 2024.

Based on CIBC World Market's 13F filing for Q4 2024, filed 23 Jan 2025.